Acerus Announces Closing of Additional US$6.5 Million Financing From First Generation Capital
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced that it has closed the previously announced amendment…